How Can We Help a Patient With a Small Failing Bioprosthesis? An In Vitro Case Study

被引:28
作者
Midha, Prem A. [1 ]
Raghav, Vrishank [1 ]
Condado, Jose F. [2 ]
Arjunon, Sivakkumar [1 ]
Uceda, Domingo E. [1 ]
Lerakis, Stamatios [2 ]
Thourani, Vinod H. [2 ]
Babaliaros, Vasilis [2 ]
Yoganathan, Ajit P. [1 ]
机构
[1] Georgia Inst Technol, Atlanta, GA 30313 USA
[2] Emory Univ Hosp, Atlanta, GA 30322 USA
关键词
small bioprosthesis; transcatheter aortic valve; valve-in-valve; AORTIC-VALVE IMPLANTATION; TRANSCATHETER HEART-VALVE; SIMULATOR; GEOMETRY; STENOSIS; SHEAR;
D O I
10.1016/j.jcin.2015.08.028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aim of this study was to investigate the hemodynamic performance of a transcatheter heart valve (THV) deployed at different valve-in-valve positions in an in vitro model using a small surgical bioprosthesis. BACKGROUND Patients at high surgical risk with failing 19-mm surgical aortic bioprostheses are not candidates for valve-in-valve transcatheter aortic valve replacement, because of risk for high transvalvular pressure gradients (TVPGs) and patient-prosthesis mismatch. METHODS A 19-mm stented aortic bioprosthesis was mounted into the aortic chamber of a pulse duplicator, and a 23-mm low-profile balloon-expandable THV was deployed (valve-in-valve) in 4 positions: normal (bottom of the THV stent aligned with the bottom of the surgical bioprosthesis sewing ring) and 3, 6, and 8 mm above the normal position. Under controlled hemodynamic status, the effect of these THV positions on valve performance (mean TVPG, geometric orifice area, and effective orifice area), thrombotic potential (sinus shear stress), and migration risk (pullout force and embolization flow rate) were assessed. RESULTS Compared with normal implantation, a progressive reduction of mean TVPG was observed with each supraannular THV position (normal: 33.10 mm Hg; 3 mm: 24.69 mm Hg; 6 mm: 19.16 mm Hg; and 8 mm: 12.98 mm Hg; p < 0.001). Simultaneously, we observed increases in geometric orifice area (normal: 0.83 cm(2); 8 mm: 1.60 cm(2); p < 0.001) and effective orifice area (normal: 0.80 cm2; 8 mm: 1.28 cm(2); p < 0.001) and reductions in sinus shear stresses (normal: 153 dyne/cm(2); 8 mm: 40 dyne/cm(2); p < 0.001), pullout forces (normal: 1.55 N; 8 mm: 0.68 N; p < 0.05), and embolization flow rates (normal: 32.91 l/min; 8 mm: 26.06 l/min; p < 0.01). CONCLUSIONS Supra-annular implantation of a THV in a small surgical bioprosthesis reduces mean TVPG but may increase the risk for leaflet thrombosis and valve migration. A 3- to 6-mm supra-annular deployment could be an optimal position in these cases. (C) 2015 by the American College of Cardiology Foundation.
引用
收藏
页码:2026 / 2033
页数:8
相关论文
共 30 条
  • [1] [Anonymous], BIOMATER SILVER JUBI
  • [2] Transcatheter aortic valves inadequately relieve stenosis in small degenerated bioprostheses
    Azadani, Ali N.
    Jaussaud, Nicolas
    Matthews, Peter B.
    Ge, Liang
    Chuter, Timothy A. M.
    Tseng, Elaine E.
    [J]. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2010, 11 (01) : 70 - 77
  • [3] Valve-in-Valve Implantation Using a Novel Supravalvular Transcatheter Aortic Valve: Proof of Concept
    Azadani, Ali N.
    Jaussaud, Nicolas
    Matthews, Peter B.
    Ge, Liang
    Guy, T. Sloane
    Chuter, Timothy A. M.
    Tseng, Elaine E.
    [J]. ANNALS OF THORACIC SURGERY, 2009, 88 (06) : 1864 - 1870
  • [4] Delayed Migration of Sapien Valve Following a Transcatheter Mitral Valve-in-Valve Implantation
    Bapat, Vinayak Nilkanth
    Khaliel, Feras
    Ihleberg, Leo
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2014, 83 (01) : E150 - E154
  • [5] Boron W.F., 2012, Medical Physiology, V2e
  • [6] Valve-in-Valve Implantation With a 23-mm Balloon-Expandable Transcatheter Heart Valve for the Treatment of a 19-mm Stentless Bioprosthesis Severe Aortic Regurgitation Using a Strategy of "Extreme" Underfilling
    Chevalier, Florent
    Leipsic, Jonathon
    Genereux, Philippe
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2014, 84 (03) : 503 - 508
  • [7] Thrombus Formation Following Transcatheter Aortic Valve Replacement
    De Marchena, Eduardo
    Mesa, Julian
    Pomenti, Sydney
    Kall, Christian Marin y
    Marincic, Ximena
    Yahagi, Kazuyuki
    Ladich, Elena
    Kutz, Robert
    Aga, Yaar
    Ragosta, Michael
    Chawla, Atul
    Ring, Michael E.
    Virmani, Renu
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (05) : 728 - 739
  • [8] Coronary Obstruction in Transcatheter Aortic Valve-in-Valve Implantation Preprocedural Evaluation, Device Selection, Protection, and Treatment
    Dvir, Danny
    Leipsic, Jonathon
    Blanke, Philipp
    Ribeiro, Henrique B.
    Kornowski, Ran
    Pichard, Augusto
    Rodes-Cabau, Joseph
    Wood, David A.
    Stub, Dion
    Ben-Dor, Itsik
    Maluenda, Gabriel
    Makkar, Raj R.
    Webb, John G.
    [J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (01)
  • [9] Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Surgical Valves
    Dvir, Danny
    Webb, John G.
    Bleiziffer, Sabine
    Pasic, Miralem
    Waksman, Ron
    Kodali, Susheel
    Barbanti, Marco
    Latib, Azeem
    Schaefer, Ulrich
    Rodes-Cabau, Josep
    Treede, Hendrik
    Piazza, Nicolo
    Hildick-Smith, David
    Himbert, Dominique
    Walther, Thomas
    Hengstenberg, Christian
    Nissen, Henrik
    Bekeredjian, Raffi
    Presbitero, Patrizia
    Ferrari, Enrico
    Segev, Amit
    de Weger, Arend
    Windecker, Stephan
    Moat, Neil E.
    Napodano, Massimo
    Wilbring, Manuel
    Cerillo, Alfredo G.
    Brecker, Stephen
    Tchetche, Didier
    Lefevre, Thierry
    De Marco, Federico
    Fiorina, Claudia
    Petronio, Anna Sonia
    Teles, Rui C.
    Testa, Luca
    Laborde, Jean-Claude
    Leon, Martin B.
    Kornowski, Ran
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (02): : 162 - 170
  • [10] Transcatheter Aortic Valve-in-Valve Implantation for Patients With Degenerative Surgical Bioprosthetic Valves
    Dvir, Danny
    Barbanti, Marco
    Tan, John
    Webb, John G.
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2014, 39 (01) : 7 - 27